August 23, 2017 9:00 am
The ability of continuous manufacturing to eliminate the need for process scale up during drug development may be the greatest prize for makers of pharmaceutical products.
August 18, 2017 9:00 am
Armed with the right people, strategy, process, and technology, life sciences organizations can reap the rewards of successful global expansion.
August 16, 2017 9:00 am
Since barcode performance affects business performance, it’s important to know the difference between barcode reading (also called scanning) barcode grading (a.k.a. verifying).
August 14, 2017 9:00 am
How migrating to MES technology can help companies optimize their performance and how implementing a support model can maximize investment.
August 11, 2017 9:00 am
Pharmacovigilance as a discipline should not be confined to regulatory compliance. Leading life sciences companies are using it to shape a number of strategic priorities, from M&A decisions to product innovation.
August 9, 2017 10:50 am
As of June 30, 2017, the U.S. FDA extended the Product Identifier Requirements under the Drug Supply Chain Security Act (DSCSA). Companies will no longer be penalized if they don't meet the November 27, 2017 serialization deadline. So, what does that mean for pharmaceutical manufacturers going forward?
August 9, 2017 9:00 am
Forward-thinking organizations are automating systems so that, after initial implementation, regulatory bodies can be updated on progress quickly and provided with the necessary information in the required format.
August 7, 2017 9:00 am
Because harmful contamination can occur at any point in the manufacturing and packaging process, no single step can be taken to eliminate the risk entirely.
August 4, 2017 9:00 am
Data management is key to keeping trials on track and bringing drugs to market in a timely way.
July 31, 2017 9:00 am
As the U.K. faces the Brexit deadline, EU member states have until the end of today to submit bids for the relocation of the European Medicines Agency (EMA). Rory Mullen of IDA Ireland offered the perspective from that bidding nation.
- 1 of 3
- next ›